Sargent Investment Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
16,839
+1,057
+7% +$85.3K 0.16% 109
2026
Q1
$1.37M Buy
15,782
+2,245
+17% +$215K 0.18% 102
2025
Q4
$1.3M Buy
13,537
+548
+4% +$53.2K 0.16% 101
2025
Q3
$1.24M Buy
12,989
+2,790
+27% +$256K 0.18% 88
2025
Q2
$911K Buy
10,199
+2,951
+41% +$250K 0.12% 108
2025
Q1
$651K Buy
7,248
+1,704
+31% +$152K 0.1% 122
2024
Q4
$453K Buy
+5,544
New +$480K 0.07% 140

Other funds holding MDT

Sargent Investment Group's MDT Position: Q2 2026 in Review

Sargent Investment Group increased its Medtronic (MDT) stake by 6.7% in Q2 2026, buying an estimated $85.3K and bringing the position to 16,839 shares worth $1.32M. The position accounts for 0.16% of the portfolio, ranked #109.

Sargent Investment Group first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.37M in Q1 2026. 2,141 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Sargent Investment Group held 16,839 shares of Medtronic worth $1.32M as of Q2 2026.
  • Sargent Investment Group bought 1,057 Medtronic shares in Q2 2026, an estimated $85.3K.
  • Medtronic made up 0.16% of Sargent Investment Group's portfolio in Q2 2026, its #109 holding.
  • Sargent Investment Group first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Sargent Investment Group's Medtronic position peaked at $1.37M in Q1 2026.
  • 2,141 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.